Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA wants faster compliance

This article was originally published in The Silver Sheet

Executive Summary

Companies must speed up responses to regulatory problems, CDRH Office of Compliance Director Tim Ulatowski said at the 2009 Parenteral Drug Association/FDA Joint Regulatory Conference, held Sept. 14-18 in Washington, D.C. "Today is a new day at FDA," Ulatowski said. "The commissioner's message is very plain, very clear." When it comes to product recalls, "the press release goes [out] today. The action is taken today," he said. "Industry has to get up to the speed that the agency is now working. Otherwise, you're going to be totally shocked at the response you're getting over the phone or in person from us.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT036398

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel